BALA CYNWYD, Pa., Sept. 29, 2012 /PRNewswire/ -- Law office of
Brodsky & Smith, LLC announces that it is investigating
potential claims against the Board of Directors of Physicians
Formula Holdings, Inc. ("Physicians Formula" or the "Company")
(Nasdaq: FACE) relating to the proposed acquisition by Markwins
International Corp. ("Markwins").
Under the terms of the transaction, Physicians Formula
shareholders will receive only $4.90
in cash for each share of Physicians Formula stock they own. The
investigation concerns possible breaches of fiduciary duty and
other violations of state law by the Board of Directors of
Physicians Formula for not acting in the Company's shareholders'
best interests in connection with the sale process to Markwins. The
transaction may undervalue the Company as the transaction
represents little or no premium for Physicians Formula
shareholders. For example Physicians Formula stock traded at
$4.88 as recently as September 17, 2012 and traded at $5.79 on May 11,
2011.
If you own shares of Physicians Formula stock and wish to
discuss the legal ramifications of the proposed transaction, or
have any questions, you may e-mail or call the law office of
Brodsky & Smith, LLC who will, without obligation or cost to
you, attempt to answer your questions. You may contact
Jason L. Brodsky, Esquire or
Evan J. Smith, Esquire at Brodsky
& Smith, LLC, Two Bala Plaza, Suite 602, Bala Cynwyd, PA 19004, by e-mail at
investorrelations@brodsky-smith.com visiting
http://brodsky-smith.com/482-face-physicians-formula-holdingsinc.html,
by calling toll free 877-LEGAL-90.
SOURCE Brodsky & Smith, LLC